Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men

Khosla, Sundeep, Melton, L Joseph, Robb, Richard A, Camp, Jon J, Atkinson, Elizabeth J, Oberg, Ann L, Rouleau, Peggy A, Riggs, B Lawrence · 2005 · Journal of Bone and Mineral Research

Abstract

In a population-based, cross-sectional study, we related age-associated changes in vBMD and in bone structural parameters to circulating bioavailable estradiol and testosterone levels in men. Associations between these bone mass/structural parameters and sex steroid levels were progressively stronger with age. Our previously postulated “threshold” for skeletal estrogen deficiency was most evident at cortical sites. Introduction: Serum sex steroids, particularly estrogen levels, are associated with bone mass in men, and previous work has suggested that there may be a “threshold” bioavailable estradiol (bio E2) level below which the male skeleton becomes estrogen deficient. However, previous studies addressing this issue have exclusively used DXA, which cannot separate trabecular from cortical bone or provide information on bone geometry or structure. Materials and Methods: In an age-stratified population sample of 314 men (age, 22-91 years), we assessed volumetric BMD (vBMD) and bone geometry by QCT at the lumbar spine, femoral neck, distal radius, and distal tibia and related these to circulating bio E2 and bio testosterone (T) levels. Results: Compared with young men (age, 20-39 years), middle-aged men (age, 40-59 years) had significantly lower bio T (−26%, p < 0.001) and bio E2 (−9%, p = 0.038) levels, and these decreases were even greater in the elderly men (age ≥ 60 years, −60% and −38% for bio T and bio E2, respectively, p < 0.001 for both). Reflecting their intact gonadal status, vBMD/structural parameters were not related to sex steroid levels in young men, whereas bio E2 levels were associated consistently with vBMD and variably with bone geometric parameters in the elderly men; middle-aged men showed associations with bio E2 and bio T at some sites. At all cortical sites, vBMD was associated with bio E2 at low (<30 pM, R = 0.27-0.41, p < 0.05-0.001) but not high (≥30 pM, R = −0.003 to 0.12, p = not significant) levels; no such differences were evident at trabecular sites. Conclusions: In men, bio E2 is the most consistent predictor of vBMD and some bone geometric variables as assessed by QCT. We also extend our previous findings on a possible “threshold” for skeletal estrogen deficiency by showing that this is most evident for cortical sites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1359/jbmr.041228

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 22

  1. Greendale, 1997, Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study, J Bone Miner Res, 12, 1833, 10.1359/jbmr.1997.12.11.1833 · DOI · Paper page
  2. Khosla, 1998, Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen, J Clin Endocrinol Metab, 83, 2266
  3. Center, 1999, Hormonal and biochemical parameters in the determination of osteoporosis in elderly men, J Clin Endocrinol Metab, 84, 3626
  4. Amin, 2000, Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study, Ann Intern Med, 133, 951, 10.7326/0003-4819-133-12-200012190-00010 · DOI · Paper page
  5. Khosla, 2001, Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men, J Clin Endocrinol Metab, 86, 3555, 10.1210/jcem.86.8.7736 · DOI · Paper page
  6. Van Pottelbergh, 2003, Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age, J Clin Endocrinol Metab, 88, 3075, 10.1210/jc.2002-021691 · DOI · Paper page
  7. Gennari, 2003, Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men, J Clin Endocrinol Metab, 88, 5327, 10.1210/jc.2003-030736 · DOI · Paper page
  8. Bouxsein, 2001, Osteoporosis, 509, 10.1016/B978-012470862-4/50020-9 · DOI
  9. Camp, 2004, A system for the analysis of whole-bone strength from helical CT images, Proc SPIE, 5369, 74, 10.1117/12.535745 · DOI
  10. Cann, 1988, Quantitative CT for determination of bone mineral density: A review, Radiology, 166, 509, 10.1148/radiology.166.2.3275985 · DOI · Paper page
  11. O'Connor, 1973, The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation, J Steroid Biochem, 4, 331, 10.1016/0022-4731(73)90002-2 · DOI
  12. Tremblay, 1974, Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives, Contraception, 10, 599, 10.1016/0010-7824(74)90099-7 · DOI · Paper page
  13. Cummings, 2002, Clinical use of bone densitometry, JAMA, 288, 1889, 10.1001/jama.288.15.1889 · DOI · Paper page
  14. Seeman, 1997, From density to structure: Growing up and growing old on the surfaces of bone, J Bone Miner Res, 12, 509, 10.1359/jbmr.1997.12.4.509 · DOI · Paper page
  15. Valimaki, 2004, Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men, J Clin Endocrinol Metab, 89, 3785, 10.1210/jc.2003-032187 · DOI
  16. Ahlborg, 2003, Bone loss and bone size after menopause, N Engl J Med, 349, 327, 10.1056/NEJMoa022464 · DOI · Paper page
  17. Genant, 1982, Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy, Ann Intern Med, 97, 699, 10.7326/0003-4819-97-5-699 · DOI · Paper page
  18. Smith, 2001, Pamidronate to prevent bone loss in men receiving gonadotropin releasing hormone agonist therapy for prostate cancer, N Engl J Med, 345, 948, 10.1056/NEJMoa010845 · DOI · Paper page
  19. Bord, 2001, Estrogen receptors alpha and beta are differentially expressed in developing human bone, J Clin Endocrinol Metab, 86, 2309
  20. Onoe, 1997, Expression of estrogen receptor beta in rat bone, Endocrinology, 138, 4509, 10.1210/endo.138.10.5575 · DOI · Paper page
  21. Modder, 2004, Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice, Endocrinology, 145, 913, 10.1210/en.2003-1089 · DOI
  22. Hall, 1999, The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens, Endocrinology, 140, 5566, 10.1210/endo.140.12.7179 · DOI · Paper page

Cited by

See all 162

Metadata

Authors
Khosla, S., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Oberg, A. L., Rouleau, P. A., & Riggs, B. L.
Venue
Journal of Bone and Mineral Research
Published
2005-05-01
Volume
20
Issue
5
Pages
730-740
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W1992140239
Cited by
162
References
10
FWCI
14.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men. https://app.cochat.ai/papers/10.1359/jbmr.041228
The paper
Khosla, S., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Oberg, A. L., Rouleau, P. A., & Riggs, B. L. (2005). Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.041228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.